Biogen, Inc. (BIIB)
175.84
-4.60
(-2.55%)
USD |
NASDAQ |
Dec 09, 16:00
170.47
-5.37
(-3.05%)
After-Hours: 05:26
Biogen Total Assets (Quarterly): 29.21B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amgen, Inc. | 90.14B |
| Eli Lilly & Co. | 114.94B |
| Merck & Co., Inc. | 129.55B |
| Pfizer Inc. | 208.73B |
| Stoke Therapeutics, Inc. | 360.26M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 11.00B |
| Shareholders Equity (Quarterly) | 18.21B |
| Debt to Equity Ratio | 0.3619 |
| Current Ratio | 2.716 |
| Net Debt Paydown Yield | 0.07% |